[go: up one dir, main page]

NO992727D0 - Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen - Google Patents

Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen

Info

Publication number
NO992727D0
NO992727D0 NO992727A NO992727A NO992727D0 NO 992727 D0 NO992727 D0 NO 992727D0 NO 992727 A NO992727 A NO 992727A NO 992727 A NO992727 A NO 992727A NO 992727 D0 NO992727 D0 NO 992727D0
Authority
NO
Norway
Prior art keywords
pancreas
diagnostic agents
exocrine function
exocrine
function
Prior art date
Application number
NO992727A
Other languages
English (en)
Other versions
NO323757B1 (no
NO992727L (no
Inventor
Tadashi Kohno
Iasaburo Hosoi
Junko Ohshima
Kunihiko Shibata
Asuka Ito
Original Assignee
Tokyo Gas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Gas Co Ltd filed Critical Tokyo Gas Co Ltd
Publication of NO992727D0 publication Critical patent/NO992727D0/no
Publication of NO992727L publication Critical patent/NO992727L/no
Publication of NO323757B1 publication Critical patent/NO323757B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206Administration of radioactive gases, aerosols or breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • A61K49/1815Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Atmospheric Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19992727A 1998-06-05 1999-06-04 Diagnostiske midler for pankreasksokrin funksjon i en pustetest, samt 13C- eller 14C-merket forbindelse eller salt. NO323757B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15785598 1998-06-05
JP14949699A JP3340699B2 (ja) 1998-06-05 1999-05-28 膵外分泌機能診断剤

Publications (3)

Publication Number Publication Date
NO992727D0 true NO992727D0 (no) 1999-06-04
NO992727L NO992727L (no) 1999-12-06
NO323757B1 NO323757B1 (no) 2007-07-02

Family

ID=26479372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992727A NO323757B1 (no) 1998-06-05 1999-06-04 Diagnostiske midler for pankreasksokrin funksjon i en pustetest, samt 13C- eller 14C-merket forbindelse eller salt.

Country Status (10)

Country Link
EP (1) EP0966975B1 (no)
JP (1) JP3340699B2 (no)
AU (1) AU729896B2 (no)
CA (1) CA2273549C (no)
DE (1) DE69927089T2 (no)
DK (1) DK0966975T3 (no)
ES (1) ES2249873T3 (no)
NO (1) NO323757B1 (no)
NZ (1) NZ336116A (no)
PT (1) PT966975E (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284219B1 (en) 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
US7232559B1 (en) * 1999-06-04 2007-06-19 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤
US7125683B2 (en) * 2000-09-07 2006-10-24 Tokyo Gas Company Limited Preparations for diagnosis extrapancreatic secretory function
NZ530072A (en) * 2001-08-10 2005-05-27 Tokyo Gas Co Ltd Diagnostic agents for pancreatic exocrine function
US7781396B2 (en) 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US20070021345A1 (en) 2003-06-30 2007-01-25 Ehud Gazit Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
AU2003211602B2 (en) * 2002-02-21 2008-05-22 Tokyo Gas Company Limited Diagnostic reagent for evaluation of pharmacological effect of medicine, and method and reagent for screening pharmaceutical agents comprising enzyme, enzyme inhibitor or receptor ligand and/or prodrugs thereof for one having high medicative efficacy and/or small side effect
EP1478407A1 (en) * 2002-02-27 2004-11-24 Cambridge Isotope Laboratories, Inc. Use of 13c labelled substance for measuring lung function
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
ATE426575T1 (de) 2003-01-07 2009-04-15 Univ Ramot Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
EP1663199B1 (en) 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
US7625707B2 (en) 2003-10-02 2009-12-01 Ramot At Tel Aviv University Ltd. Antibacterial agents and methods of identifying and utilizing same
EP1781310B1 (en) 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
ATE539745T1 (de) 2004-08-19 2012-01-15 Univ Tel Aviv Future Tech Dev Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
US7786086B2 (en) 2004-09-08 2010-08-31 Ramot At Tel-Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
CA2587985C (en) 2004-11-24 2016-05-10 Neopro Labs, Llc Peptides for use in treatment in fever or pain
WO2007043048A2 (en) 2005-10-11 2007-04-19 Ramot At Tel Aviv University Ltd. Self-assembled fmoc-ff hydrogels
US7879212B2 (en) 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
US7557088B2 (en) 2006-03-28 2009-07-07 Neopro Labs, Llc Methods and compositions for treating conditions
CA2683288A1 (en) 2007-05-17 2008-11-27 Neopro Labs, Llc Crystalline and amorphous forms of peptide
TR2021004329A2 (tr) * 2021-03-05 2022-09-21 Argeron Medikal Arastirma Sanayi Ve Ticaret Anonim Sirketi Bi̇yoki̇myasal tibbi̇ tani ki̇ti̇
US12036286B2 (en) 2021-03-18 2024-07-16 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4279886A (en) * 1979-01-02 1981-07-21 University Patents, Inc. Test for pancreatic exocrine function
US4676974A (en) * 1984-05-17 1987-06-30 The Regents Of The University Of California Breath test for pancreatic exocrine function
US5506147A (en) 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
JP2001511152A (ja) * 1997-02-03 2001-08-07 マリンクロッド・インコーポレイテッド 悪性ヒト腫瘍の検出および位置特定法
US6284219B1 (en) * 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
NZ507949A (en) * 1998-09-25 2002-03-01 Tokyo Gas Co Ltd C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
JP2001139498A (ja) * 1999-11-15 2001-05-22 Tokyo Gas Co Ltd 膵外分泌機能診断剤

Also Published As

Publication number Publication date
EP0966975A2 (en) 1999-12-29
DK0966975T3 (da) 2005-10-03
PT966975E (pt) 2005-11-30
DE69927089T2 (de) 2006-05-18
CA2273549A1 (en) 1999-12-05
ES2249873T3 (es) 2006-04-01
DE69927089D1 (de) 2005-10-13
NZ336116A (en) 2000-10-27
AU3316899A (en) 1999-12-16
AU729896B2 (en) 2001-02-15
CA2273549C (en) 2006-10-24
JP2000053697A (ja) 2000-02-22
NO323757B1 (no) 2007-07-02
EP0966975B1 (en) 2005-09-07
EP0966975A3 (en) 2002-04-17
NO992727L (no) 1999-12-06
JP3340699B2 (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
NO992727D0 (no) Diagnostiske midler for eksokrin funksjon til bukspyttkjertelen
DE69907371D1 (de) Verriegelungsanordnung
TR199901877A3 (tr) Zararli eklem bacaklilarin imhasi için terkip.
NO20000857L (no) Blandeapparat
DE69908791D1 (de) Indirekt betätigbarer verschluss
ID25510A (id) Komposisi anti keringat atau deodoran
DE69908446D1 (de) Programmfehlerbeseitigung
DE69935145D1 (de) Steckverbinderanordnung
DE59912684D1 (de) Folienförmige wirkstoffträger
DK1109450T3 (da) Mikrokapselpræparater
DK1064519T3 (da) Toakset gyroskop
ATE286131T1 (de) Attenuierte pestiviren
DE69925490D1 (de) Polyisocyanatzusammensetzungen
DE69900351D1 (de) Prüfkopfanordnung
NO20005507D0 (no) Spylerenseapparat
DE59910200D1 (de) Kühlbares Bauteil
NO982014L (no) Fremgangsmåte for beregning av varighet av oppkoblinger
NO20022367L (no) Låssammenstilling
TR199900594A3 (tr) Bulasik makinasi.
FR2784200B1 (fr) Composant monolithique electro-optique multi-sections
ID22484A (id) Lempeng penahan untuk kumparan atau sejenisnya
IT1291997B1 (it) Preparati-farmaceutici-topici-contenenti nimesulide
NO20011268D0 (no) Forbindelse til behandling av depresjon
FI3524U1 (fi) Yhdistelmäkoura
ATA35798A (de) Flüssigkeitssperre

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees